Fig. 3From: Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysisFunnel plots based on overall survival a Begg’s test b Egger’s test; and progression-free survival c Begg’s test d Egger’s testBack to article page